World's Best Scientists 2026 revealed!
Paolo Corradini

Paolo Corradini

D-Index & Metrics

Medicine

D-Index
100
Citations
34856
World Ranking
8310
National Ranking
275

Overview

Paolo Corradini is affiliated with the University of Milan in Italy. Their academic profile reflects a focus on higher education and research conducted within this institution.

While specific recent publications, frequent co-authors, and dominant research topics are not detailed, Paolo Corradini's connection to the University of Milan situates them within a notable academic environment known for its contributions across multiple disciplines.

The absence of listed papers, awards, or fields of study suggests that the available data does not provide detailed insights into their research specialization or publication record.

There is no information regarding book publications or involvement in specific subfields or topics of study.

Given the lack of additional documented scholarly output or notable collaborations, the profile remains limited to their primary institutional affiliation and identity as an active researcher.

Best Publications

  • Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

    Michele Cavo;Paola Tacchetti;Francesca Patriarca;Maria Teresa Petrucci

  • Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

    Jesús F. San-Miguel;Vânia T.M. Hungria;Sung Soo Yoon;Meral Beksac

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study

    Michel Attal;Paul G. Richardson;S. Vincent Rajkumar;Jesus San-Miguel

  • Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

    Francesco Passamonti;Chiara Cattaneo;Luca Arcaini;Riccardo Bruna

  • B cell lymphoma-associated chromosomal translocation involves candidate oncogene lyt-10, homologous to NF-κB p50

    Antonino Neri;Antonino Neri;Chih Chao Chang;Luigia Lombardi;Mauro Salina

  • Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.

    Stephen J. Schuster;Constantine S. Tam;Peter Borchmann;Nina Worel

  • Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

    Nicolaus Kröger;Ernst Holler;Guido Kobbe;Martin Bornhäuser

  • Indications for allogeneic stem cell transplantation in chronic lymphocytic leukemia: the EBMT transplant consensus.

    P Dreger;P Corradini;E Kimby;M Michallet

  • Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma

    F. Lo Coco;B. H. Ye;F. Lista;P. Corradini

  • Graft-Versus-Lymphoma Effect in Relapsed Peripheral T-Cell Non-Hodgkin's Lymphomas After Reduced-Intensity Conditioning Followed by Allogeneic Transplantation of Hematopoietic Cells

    Paolo Corradini;Anna Dodero;Francesco Zallio;Daniele Caracciolo

  • Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma

    Shinsuke Iida;Pulivarthi H. Rao;Marion Butler;Paolo Corradini

  • Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

    Antonio Palumbo;Patrizia Falco;Paolo Corradini;Antonietta Falcone

  • Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial.

    Stefania Oliva;Maria Teresa Petrucci;Concetta Conticello

  • Allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia in Europe 2006: transplant activity, long-term data and current results. An analysis by the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

    Alois Gratwohl;Ronald Brand;Jane Apperley;Charles Crawley

  • Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

    Alessandra Larocca;Federica Cavallo;Sara Bringhen;Francesco Di Raimondo

  • Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

    Bihui H. Ye;Seeta Chaganti;Chih Chao Chang;Huifeng Niu

  • Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

    Marco Ladetto;Federica De Marco;Fabio Benedetti;Umberto Vitolo

  • Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation.

    P Corradini;C Tarella;F Zallio;A Dodero

  • Molecular and Clinical Remissions in Multiple Myeloma: Role of Autologous and Allogeneic Transplantation of Hematopoietic Cells

    Paolo Corradini;Claudia Voena;Corrado Tarella;Monica Astolfi

Frequent Co-Authors

Mario Boccadoro
Mario Boccadoro University of Turin
Antonio Palumbo
Antonio Palumbo University of Turin
Alessandro Rambaldi
Alessandro Rambaldi University of Milan
Fabio Ciceri
Fabio Ciceri Vita-Salute San Raffaele University
Gaetano Guerra
Gaetano Guerra University of Salerno
Michele Cavo
Michele Cavo University of Bologna
Alberto Bosi
Alberto Bosi University of Florence
Umberto Vitolo
Umberto Vitolo University of Turin
Maria Teresa Petrucci
Maria Teresa Petrucci Sapienza University of Rome
Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If a traditional medical degree isn't the perfect fit, there are many alternative healthcare pathways to consider. Online nursing programs are a popular choice, offering flexibility and a range of specializations for students. Prospective nurses often ask how much is online nursing school, and costs can vary significantly by program and school.

Those looking to advance their nursing careers may be interested in the cheapest np school online options, which can help students progress to advanced practice roles at a lower cost.

For registered nurses aiming to expand their qualifications, understanding the rn to bsn online cost is a critical first step. Programs like these allow RNs to earn their bachelor’s degree with flexibility and affordability.

Those interested in research or academic leadership may pursue a phd in nursing. These advanced degrees open doors to teaching and specialized practice, supporting ongoing growth in the healthcare sector.

Best Scientists Citing Paolo Corradini

Trending Scientists

Recently Published Articles